XML 49 R34.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stock Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Stock Based Compensation  
Schedule of option activity under the Plan

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted-average

​

​

​

​

​

​

​

Remaining

​

​

Number of

​

Weighted-average

​

Contractual Term

Options

    

Options

    

Exercise Price

    

(in years)

Outstanding at January 1, 2024

​

24,264,016

​

$

2.53

​

7.03

Granted

​

6,324,127

​

$

1.59

​

​

Exercised

​

(5,141,728)

​

$

0.05

​

​

Forfeited or expired

​

(4,840,722)

​

$

3.26

​

​

Outstanding at December 31, 2024

​

20,605,693

​

$

2.45

​

6.68

​

​

​

​

​

​

​

​

Exercisable at December 31, 2023

​

16,662,487

​

$

1.99

​

4.87

Exercisable at December 31, 2024

​

12,275,078

​

$

2.48

​

5.27

Schedule of restricted stock grants to non employees

​

​

​

​

​

​

​

​

​

​

For the Years Ended December 31, 

​

    

2024

    

2023

Restricted stock grants to non-employees

​

​

298,508

​

​

—

Schedule of recognized & allocated compensation costs

​

​

​

​

​

​

​

​

​

​

For the Years Ended December 31, 

​

​

2024

    

2023

Stock-based compensation costs related to RSUs

​

$

5,662

​

$

3,427

Stock-based compensation costs related to stock options

​

 

6,138

​

 

6,774

Stock-based compensation costs related to the ESPP

​

​

172

​

​

169

Total equity-based compensation costs

​

$

11,972

​

$

10,370

​

​

​

​

​

​

​

​

​

​

For the Years Ended December 31, 

​

​

2024

 

2023

Direct costs

​

$

1,131

​

$

3,751

Research and development

​

​

4,463

​

​

4,826

Selling, general and administrative

​

​

6,378

​

​

1,793

Total equity-based compensation cost

​

$

11,972

​

$

10,370

Schedule of fair value of each option using the Black-Scholes option pricing model

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

2024

 

2023

 

Approximate risk‑free rate

​

​

4.23

%

​

4.17

%

Volatility

​

​

48.1

%

​

46.91

%

Average expected life (in years)

​

​

6

​

​

6

​

Dividend yield

​

​

0

%

​

0

%

Weighted‑average grant date fair value

​

$

0.82

​

$

1.42

​

Estimated fair value of total stock options granted

​

$

5,175

​

$

7,815

​

Restricted stock units (RSUs)  
Stock Based Compensation  
Schedule of non-vested Restricted stock units

​

​

​

​

​

​

​

​

​

Number of

    

Weighted-average

​

​

RSUs

​

Grant Date Fair Value

Balance at December 31, 2023

​

4,473,016

​

​

3.30

Granted

​

6,792,700

​

​

1.58

Vested or Exercised

​

(1,601,279)

​

​

2.89

Forfeited

​

(1,463,884)

​

​

2.26

Balance at December 31, 2024

​

8,200,553

​

​

3.10

Restricted stock  
Stock Based Compensation  
Schedule of non-vested Restricted stock units

​

​

​

​

​

​

​

​

Number of

    

Weighted-average

​

​

Grants

​

Grant Date Fair Value

Balance at December 31, 2023

​

—

​

—

Granted

​

298,508

​

1.23

Vested

​

(59,702)

​

1.23

Forfeited

​

—

​

—

Balance at December 31, 2024

​

238,806

​

1.23

2021 Equity Incentive Plan  
Stock Based Compensation  
Schedule of option activity under the Plan

​

​

​

​

​

​

​

​

​

​

For the Years Ended December 31, 

​

    

2024

    

2023

Option awards granted under 2021 Plan

​

​

6,324,127

​

​

5,176,889

RSU awards granted under 2021 Plan

​

​

6,792,700

​

​

4,663,079